JP Stock MarketDetailed Quotes

4886 ASKA Pharmaceutical Holdings

Watchlist
  • 2309
  • +21+0.92%
20min DelayMarket Closed Aug 19 15:00 JST
70.57BMarket Cap8.66P/E (Static)

ASKA Pharmaceutical Holdings Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ASKA Pharmaceutical Holdings Q1 2025 Earnings Date

Currency：JPYAug 5, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
16.42B
16.35B
-68.00M
Miss Est.
+2.48%
+2.05%
-0.41%
NI to Common Holders
--
1.27B
--
-10.85%
Analyst Rating
Buy

Jun 26, 2024

ASKA Pharmaceutical Holdings Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 17.540B--
--2025/Q2-- / 16.030B--
Aug 5, 20242025/Q116.352B / 16.420B--
May 10, 20242024/Q414.019B / 14.176B--
Feb 5, 20242024/Q317.176B / 17.430B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 17.540B--
--2025/Q2-- / 16.030B--
Aug 5, 20242025/Q116.352B / 16.420B--
May 10, 20242024/Q414.019B / 14.176B--
Feb 5, 20242024/Q317.176B / 17.430B--

Unlock Free Earnings Estimates

ASKA Pharmaceutical Holdings Earnings Reports

  • ASKA Pharmaceutical Holdings: Supplementary information for the fiscal Q1 financial statement for March 2025.

    Aug 5 02:00 ET

  • ASKA Pharmaceutical Holdings: Short message of Q1 financial results for March 2025 (consolidated, Japanese standard).

    Aug 5 02:00 ET

  • ASKA Pharmaceutical Holdings: Extraordinary Report

    Jun 28 01:12 ET

  • ASKA Pharmaceutical Holdings: Confirmation letter

    Jun 25 00:40 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 26, 2024

    Buy

    • Strong Buy

      50.00%

    • Buy

      0.00%

    • Hold

      50.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg